GlassScriptPhysician profile
John C Zimmerman
NPI 1235220211
$27,297.95
in general payments reported to CMS, 2019-2025
11 companies · $68.19 in 2025
The $68.19 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,052 · 2020: $713 · 2021: $21K · 2022: $26.83 · 2023: $25.89 · 2024: $196 · 2025: $68.19.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $290.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $289.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Heron Therapeutics, INC. | $19,524.92 | 2019-2021 | |
| Baudax Bio INC. | $7,194.37 | 2021 | |
| Smith+Nephew, INC. | $222.58 | 2021-2025 | Stravix Pl, Collagenase Santyl |
| Astrazeneca Pharmaceuticals LP | $109.38 | 2024 | Imfinzi |
| Cornerstone Medical Associates, INC. | $97.16 | 2023-2025 | |
| Zimmer Biomet Holdings, INC. | $80.92 | 2019 | |
| Organogenesis INC. | $39.25 | 2024 | Cygnus Dual, Puraply Am |
| Bioventus LLC | $16.29 | 2019 | |
| Micromed INC | $13.08 | 2022 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Zimmerman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.